Blue Water Announces Acquisition Of Entadfi®, An Fda-Approved Benign Prostatic Hyperplasia Asset
04/20/23, 11:32 AM
Industry
natural resources
biotechnology
health care
Blue Water Vaccines Inc. (“BWV” or “Blue Water” or the “Company”), today announced the signing of an Asset Purchase Agreement (the “Agreement”) with Veru Inc. (“Veru”) for the purchase of ENTADFI®, an FDA-approved treatment for benign prostatic hyperplasia (“BPH”) that counteracts negative sexual side effects seen in men on alternative BPH therapies.
Company Info
Company info
Founded by Jack and Todd Burbage in 2002, Blue Water specializes in investing, developing, and managing RV resorts, campgrounds, hotels, and attractions. Blue Water's integrated approach to marketing, revenue management, and operations has quickly established itself as a hospitality industry leader. With dozens of resort-area properties in East Coast states from Maine to Florida, and new additions out west in Texas, Montana, and Oregon, the Blue Water family is committed to creating elite assets, delivering exceptional guest experiences, and enhancing the communities we serve. To learn more, visit BWDC.com.